Please login to the form below

Not currently logged in
Email:
Password:

Tagrisso

This page shows the latest Tagrisso news and features for those working in and with pharma, biotech and healthcare.

AZ makes case for first-line Tagrisso therapy in lung cancer

AZ makes case for first-line Tagrisso therapy in lung cancer

using Tagrisso (osimertinib) first-line in EGFR-mutated non-small cell lung cancer (NSCLC). ... These findings build on the clinically-meaningful PFS benefit of Tagrisso and reinforce its potential as a new standard of care, ”said Bohen.

Latest news

More from news
Approximately 20 fully matching, plus 18 partially matching documents found.

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Real Science Communications

Real Science Communications is a scientific centre of excellence, infusing credibility and scientific rigour into the conversations around health and...

Latest intelligence

Why heading online for scientific meetings can yield greater HCP engagement
Modern conferencing methods, with enhanced digital information transfers, offer unique opportunities for greater HCP engagement....
The threat of antimicrobial resistance
Why this issue is such a fundamental challenge...
Meet the CEO behind ReNeuron’s cutting-edge stem cell therapies
Blue Latitude Health speaks to Olav Hellebo, CEO of ReNeuron, to find out about the biotech’s latest innovation in stem cell therapy and to learn his perspective on navigating the...

Infographics